Is It Possible to Perform Triple Cross-Linking of Sodium Alginate? Development of Vaginal Sponges Containing Luliconazole Based on the Alginate/Gelatin/ɛ-Poly-L-Lysine/Zinc Matrix.
5 affiliations
- 1Department of Pharmaceutical Technology, Medical University of Białystok, Mickiewicza 2C, 15-222 Białystok, Poland.
- 2Independent Laboratory of Nanomedicine, Medical University of Białystok, 15-222 Białystok, Poland.
- 3Department of Medical Microbiology and Nanobiomedical Engineering, Medical University of Białystok, 15-222 Białystok, Poland.
- 4Department of Pharmaceutical Technology, Medical University of Gdańsk, Hallera 107, 80-416 Gdańsk, Poland.
- 5Department of Polymers and Organic Synthesis, Faculty of Chemistry, University of Białystok, Ciołkowskiego 1K, 15-245 Białystok, Poland.
Abstract
Background/Objectives: Vaginal administration enables optimal drug concentrations at the site of administration, but its effectiveness is limited by factors such as the vagina's self-cleansing mechanisms and fluctuations in physiological conditions. Due to the difficulties in treating and the frequent recurrences of vaginal candidiasis, new drug formulations are required to ensure more effective therapy and sustained release of antifungal agents. Mucoadhesive vaginal sponges are a promising drug formulation providing prolonged release of the active ingredient and its contact with the vaginal mucosa. The application of polymers and their modifications plays a key role in the development of drug forms with unique and desired technological parameters. Methods: Therefore, the focus of this research was the development of a three-stage sodium alginate cross-linking technique based on polyelectrolyte complexes with gelatin and ɛ-poly-L-lysine, and additional ionic cross-linking with zinc ions, to obtain mucoadhesive vaginal sponges with an antifungal agent-luliconazole. The prepared formulations were evaluated for their pharmaceutical, mechanical, and mucoadhesive properties. In addition, antifungal and anti-biofilm action against Candida strains and compatibility with the vaginal VK2 E6/E7 epithelial cell line of the prepared sponges were assessed. Results: It was noted that the triple cross-linking process increased the mechanical properties of the developed sponges, improved mucoadhesive properties to vaginal mucosa of drug-loaded formulations, and demonstrated a sustained LUL release profile. Moreover, prepared sponges possessed improved antifungal and anti-biofilm effects against C. albicans, C. krusei, and C. parapsilosis. The prepared triple cross-linked formulations were biocompatible with the human vaginal VK2 E6/E7 epithelial cell line, depending on the exposure time and applied concentration. Conclusions: Triple cross-linked alginate sponges containing luliconazole were successfully prepared based on polyelectrolyte complexes with gelatin and ɛ-poly-L-lysine and additional ionic cross-linking with zinc ions. The triple cross-linking process of alginate improved the mechanical, mucoadhesive, and antifungal properties of the developed formulations.
Related
- Intake of foods containing phytochemicals is correlated with benign prostatic hyperplasia development: a long-term follow-up study
- Development and validation of a risk stratification model for mild cognitive impairment among older adults with possible sarcopenia integrating traditional Chinese medicine constitution: a multicenter cross-sectional study
- How to perform Doppler examination of the maternal ophthalmic artery
- Flow cytometry sperm apoptosis test can predict sperm DNA fragmentation and can be used as an effective and easy-to-perform screening method for males from infertile couples
- The Stryker Perform and Univers Apex short stems have different patterns of stress shielding but comparably low rates of loosening after reverse total shoulder arthroplasty
BibTeX
@article{szekalska2026possible,
title = {{Is It Possible to Perform Triple Cross-Linking of Sodium Alginate? Development of Vaginal Sponges Containing Luliconazole Based on the Alginate/Gelatin/ɛ-Poly-L-Lysine/Zinc Matrix.}},
author = {Marta Szekalska and Monika Trofimiuk and Ewelina Piktel and Małgorzata Sidewicz and Eliza Wolska and Jolanta Magnuszewska and Paweł Misiak and Agnieszka Zofia Wilczewska and Katarzyna Winnicka},
journal = {Pharmaceutics},
year = {2026},
month = sep,
doi = {10.3390/pharmaceutics18101238},
url = {https://europepmc.org/article/MED/42942770},
note = {CC BY},
}
RIS
TY - JOUR
TI - Is It Possible to Perform Triple Cross-Linking of Sodium Alginate? Development of Vaginal Sponges Containing Luliconazole Based on the Alginate/Gelatin/ɛ-Poly-L-Lysine/Zinc Matrix.
AU - Marta Szekalska
AU - Monika Trofimiuk
AU - Ewelina Piktel
AU - Małgorzata Sidewicz
AU - Eliza Wolska
AU - Jolanta Magnuszewska
AU - Paweł Misiak
AU - Agnieszka Zofia Wilczewska
AU - Katarzyna Winnicka
PY - 2026
DA - 2026/09/29
JO - Pharmaceutics
DO - 10.3390/pharmaceutics18101238
UR - https://europepmc.org/article/MED/42942770
AB - Background/Objectives: Vaginal administration enables optimal drug concentrations at the site of administration, but its effectiveness is limited by factors such as the vagina's self-cleansing mechanisms and fluctuations in physiological conditions. Due to the difficulties in treating and the frequent recurrences of vaginal candidiasis, new drug formulations are required to ensure more effective therapy and sustained release of antifungal agents. Mucoadhesive vaginal sponges are a promising drug formulation providing prolonged release of the active ingredient and its contact with the vaginal mucosa. The application of polymers and their modifications plays a key role in the development of drug forms with unique and desired technological parameters. Methods: Therefore, the focus of this research was the development of a three-stage sodium alginate cross-linking technique based on polyelectrolyte complexes with gelatin and ɛ-poly-L-lysine, and additional ionic cross-linking with zinc ions, to obtain mucoadhesive vaginal sponges with an antifungal agent-luliconazole. The prepared formulations were evaluated for their pharmaceutical, mechanical, and mucoadhesive properties. In addition, antifungal and anti-biofilm action against Candida strains and compatibility with the vaginal VK2 E6/E7 epithelial cell line of the prepared sponges were assessed. Results: It was noted that the triple cross-linking process increased the mechanical properties of the developed sponges, improved mucoadhesive properties to vaginal mucosa of drug-loaded formulations, and demonstrated a sustained LUL release profile. Moreover, prepared sponges possessed improved antifungal and anti-biofilm effects against C. albicans, C. krusei, and C. parapsilosis. The prepared triple cross-linked formulations were biocompatible with the human vaginal VK2 E6/E7 epithelial cell line, depending on the exposure time and applied concentration. Conclusions: Triple cross-linked alginate sponges containing luliconazole were successfully prepared based on polyelectrolyte complexes with gelatin and ɛ-poly-L-lysine and additional ionic cross-linking with zinc ions. The triple cross-linking process of alginate improved the mechanical, mucoadhesive, and antifungal properties of the developed formulations.
SN - 1999-4923
ER -